L. Boffa

发表

Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis

S. Rossi, D. Centonze, G. Bernardi, 2007, Neurology.

Differential patterns of interhemispheric functional disconnection in mild and advanced multiple sclerosis

D. Centonze, G. Bernardi, G. Koch, 2010, Multiple sclerosis.

Morphological Outer Retina Findings in Multiple Sclerosis Patients With or Without Optic Neuritis

D. Centonze, A. Grzybowski, V. Parisi, 2020, Frontiers in Neurology.

Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis

D. Centonze, G. Marfia, C. Pozzilli, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis

D. Centonze, G. Marfia, D. Landi, 2020, Journal of clinical medicine.

Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study.

V. Tomassini, C. Gasperini, A. Gallo, 2019, Multiple sclerosis and related disorders.

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis

V. Tomassini, C. Gasperini, A. Gallo, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study

V. Tomassini, C. Gasperini, A. Gallo, 2018, Journal of Neurology.

A diffusion longitudinal MR imaging study in normal-appearing white matter in untreated relapsing-remitting multiple sclerosis.

D. Centonze, F. Garaci, R. Floris, 2007, AJNR. American journal of neuroradiology.

ORIGINAL RESEARCH A Diffusion Longitudinal MR Imaging Study in Normal-Appearing White Matter in Untreated Relapsing-Remitting Multiple Sclerosis

D. Centonze, F. Garaci, R. Floris, 2007 .

Potent T cell‐mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis

N. Mercuri, S. Atamas, T. Evron, 2021, Neuropathology and applied neurobiology.

Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study

D. Centonze, G. Marfia, D. Landi, 2019, Journal of Neurology.

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression

D. Centonze, G. Marfia, M. Marciani, 2016, Journal of Neuroinflammation.

Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study

D. Centonze, D. Landi, S. Rossi, 2017, PloS one.

Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study.

D. Centonze, G. Bernardi, P. Stanzione, 2005, Journal of psychiatry & neuroscience : JPN.

Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis

D. Centonze, G. Bernardi, G. Marfia, 2007, Multiple sclerosis.

Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation

P. Rossini, D. Centonze, G. Bernardi, 2004, Clinical Neurophysiology.

CSF from MS patients can induce acute conduction block in the isolated optic nerve

D. Centonze, G. Bernardi, S. Rossi, 2005, European journal of neurology.

Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis

D. Centonze, G. Bernardi, G. Koch, 2010, European journal of neurology.

Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study

P. Pasqualetti, P. Rossini, F. Pauri, 2000, Journal of the Neurological Sciences.

Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction

N. Mercuri, C. Severini, A. Greco, 2022, Brain, Behavior, and Immunity.

Transcranial magnetic stimulation of motor pathways directed to muscles supplied by cranial nerves in amyotrophic lateral sclerosis

G. Bernardi, M. Caramia, M. Desiato, 2002, Clinical Neurophysiology.

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression

D. Centonze, G. Marfia, M. Marciani, 2016, Journal of Neuroinflammation.

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

L. Grimaldi, A. Gallo, M. C. Buscarinu, 2018, Journal of Neurology.

Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study

D. Centonze, G. Marfia, C. Pozzilli, 2018, CNS Drugs.

Pramipexole in comparison to l-dopa: a neuropsychological study

P. Stanzione, A. Stefani, A. Peppe, 2003, Journal of Neural Transmission.

Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids

D. Centonze, F. Barbieri, S. Rossi, 2014, CNS neuroscience & therapeutics.

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

V. Tomassini, L. Roccatagliata, B. Bodini, 2013, Neurological Sciences.

Fampridine improves acute optic neuritis contributing to a long-lasting recovery of nerve function

N. Mercuri, V. Parisi, L. Ziccardi, 2021, Neurological Sciences.

Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis

D. Centonze, N. Mercuri, G. Marfia, 2018, CNS Drugs.

Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.

M. Chimenti, P. Triggianese, P. Conigliaro, 2020, Clinical and experimental rheumatology.

Informing MS patients on treatment options: a consensus on the process of consent taking

M. Filippo, C. Gasperini, P. Ragonese, 2020, Neurological Sciences.